Free Trial

Swedbank AB Raises Stock Holdings in The Clorox Company $CLX

Clorox logo with Consumer Staples background

Key Points

  • Swedbank AB increased its stake in The Clorox Company by 18% in the second quarter, owning 192,504 shares valued at approximately $23.1 million as of the latest SEC filing.
  • Clorox reported earnings of $2.87 per share for the last quarter, surpassing analyst expectations and showcasing a revenue increase of 4.5% compared to the previous year.
  • The company announced a quarterly dividend of $1.24 per share, with an annualized payout of $4.96 and a yield of 4.1%, set to be paid on November 6th to stockholders of record.
  • Five stocks we like better than Clorox.

Swedbank AB raised its position in The Clorox Company (NYSE:CLX - Free Report) by 18.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 192,504 shares of the company's stock after buying an additional 29,420 shares during the quarter. Swedbank AB owned approximately 0.16% of Clorox worth $23,114,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vident Advisory LLC purchased a new stake in shares of Clorox during the fourth quarter worth approximately $456,000. Vise Technologies Inc. purchased a new stake in shares of Clorox during the fourth quarter worth approximately $250,000. Public Employees Retirement System of Ohio raised its stake in shares of Clorox by 0.5% during the fourth quarter. Public Employees Retirement System of Ohio now owns 60,035 shares of the company's stock worth $9,750,000 after purchasing an additional 269 shares during the last quarter. Ball & Co Wealth Management Inc. purchased a new stake in shares of Clorox during the fourth quarter worth approximately $139,000. Finally, Mackenzie Financial Corp raised its stake in shares of Clorox by 30.5% during the fourth quarter. Mackenzie Financial Corp now owns 13,464 shares of the company's stock worth $2,187,000 after purchasing an additional 3,148 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.57% of the company's stock.

Clorox Price Performance

CLX stock opened at $121.91 on Friday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The firm has a market cap of $14.91 billion, a P/E ratio of 18.70, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52. The stock has a 50-day simple moving average of $124.04 and a 200-day simple moving average of $131.27.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same quarter last year, the firm earned $1.82 earnings per share. The company's revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be paid a $1.24 dividend. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.1%. Clorox's dividend payout ratio (DPR) is 76.07%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on CLX shares. Jefferies Financial Group cut their price target on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. Barclays cut their price target on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research note on Tuesday, July 15th. Wells Fargo & Company dropped their price objective on Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a report on Friday, September 5th. Morgan Stanley dropped their price objective on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. Finally, JPMorgan Chase & Co. upped their price objective on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a report on Monday, September 8th. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Reduce" and a consensus target price of $142.18.

View Our Latest Analysis on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.